HPC
GWPH

HM Payson & Co’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

HM Payson & Co’s Portfolio GWPH Stock Details GWPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-14
Closed -$1K – 957
2020
Q1 		$1K Hold
14
– – ﹤0.01% 892
2019
Q4 		$1K Buy
+14
New +$1.57K ﹤0.01% 917

Other funds holding GWPH

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

HM Payson & Co's GWPH Position: Q2 2020 in Review

HM Payson & Co sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q2 2020, closing a stake of 14 shares — an estimated $1K sold.

HM Payson & Co first reported a position in GWPH in Q4 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2020. 299 funds tracked by Wall St. Rank hold GWPH as of Q2 2020.

  • HM Payson & Co reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q2 2020 after selling out during the quarter.
  • HM Payson & Co sold 14 GW Pharmaceuticals Plc American Depositary Shares shares in Q2 2020, an estimated $1K.
  • HM Payson & Co first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q4 2019 and held it in 2 quarters.
  • HM Payson & Co's GW Pharmaceuticals Plc American Depositary Shares position peaked at $1K in Q1 2020.
  • 299 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q2 2020.

Based on HM Payson & Co's 13F filing for Q2 2020, filed 13 Aug 2020.